...
首页> 外文期刊>Stochastic environmental research and risk assessment >Benchmark dose calculation for ordered categorical responses with multiple endpoints
【24h】

Benchmark dose calculation for ordered categorical responses with multiple endpoints

机译:具有多个端点的有序分类响应的基准剂量计算

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The benchmark dose (BMD) approach for the exposure limit in the risk assessment of cancer and non-cancer endpoints is well established; it is often based on dose-response modeling of the most critical or the most sensitive outcome. However, neither the most critical endpoint nor the most sensitive endpoint may necessarily be representative of the overall toxic effects. To have a whole picture, it is preferable to express responses for different endpoints with equivalent severity levels and integrate them into one analysis framework. In this paper, we derive BMD in the case of multivariate ordered categorical responses such as none, mild, adverse, and severe based on structural equation models (SEMs). First, for each of the ordered categorical responses, we obtain a latent continuous variable based on fictitious cutoffs of a standard normal distribution. Second, we use SEMs to integrate the multiple continuous variables into a single latent continuous variable and derive the corresponding BMD. We employed a Bayesian statistical approach using Markov chain Monte Carlo simulations to obtain the parameter estimates of the latent variables, SEMs, and the corresponding BMD. We illustrate the proposed procedure by simulation studies and analysis of an experimental study of acrylamide exposure in mice with multivariate endpoints of different severity levels.
机译:在癌症和非癌症研究对象的风险评估中,用于暴露极限的基准剂量(BMD)方法已得到充分确立;它通常基于最关键或最敏感结果的剂量反应模型。但是,最关键的终点或最敏感的终点都不一定能代表总体毒性作用。为了全面了解情况,最好表达具有相同严重性级别的不同端点的响应,并将其集成到一个分析框架中。在本文中,我们根据结构方程模型(SEM)得出了多阶有序分类响应(如无,轻度,不利和严重)的BMD。首先,对于每个有序的分类响应,我们基于标准正态分布的虚拟边界获得潜在的连续变量。其次,我们使用SEM将多个连续变量集成到单个潜在连续变量中,并得出相应的BMD。我们采用了使用马尔可夫链蒙特卡洛模拟的贝叶斯统计方法来获得潜在变量,SEM和相应BMD的参数估计。我们通过模拟研究和对具有不同严重程度水平的多元终点的小鼠进行丙烯酰胺暴露的实验研究的分析来说明拟议的程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号